Zydus Wellness

how big is Zydus Wellness?

As of Jun 06, Zydus Wellness Ltd has a market capitalization of 12,364.68 Cr, with net sales of 2708.90 Cr and a net profit of 346.90 Cr for the latest four quarters.

Market Cap: Zydus Wellness Ltd has a market capitalization of 12,364.68 Cr and is classified as a Mid Cap company as of Jun 06.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Zydus Wellness reported net sales of 2708.90 Cr and a net profit of 346.90 Cr. This data is consolidated.<BR><BR>Balance Sheet Snapshot: The balance sheet data is consolidated for the latest annual period ending in Mar'24. Shareholder's funds are reported at 5,357.50 Cr, and total assets amount to 5,992.10 Cr.

Who are in the management team of Zydus Wellness?

As of March 2023, the management team of Zydus Wellness includes Tarun Arora (CEO), Sharvil P Patel (Chairman), and several non-executive and independent directors, overseeing the company's operations and strategic direction.

As of March 2023, the management team of Zydus Wellness includes the following members:<BR><BR>1. Ganesh N Nayak - Non-Executive & Non-Independent Director<BR>2. Sharvil P Patel - Chairman (Non-Executive)<BR>3. Tarun Arora - Whole Time Director & CEO<BR>4. Kulin S Lalbhai - Non-Executive & Independent Director<BR>5. Ashish Bhargava - Nominee<BR>6. Dharmishta N Rawal - Non-Executive & Independent Director<BR>7. Srivishnu Raju Nandyala - Non-Executive & Independent Director<BR>8. Nandish P. Joshi - Company Secretary & Compliance Officer<BR>9. Akhil A. Monappa - Independent Director<BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

Has Zydus Wellness declared dividend?

Zydus Wellness Ltd has declared a 50% dividend, amounting to ₹5 per share, with an ex-date of July 19, 2024. The dividend yield is 0.26%, and total returns over the past five years stand at 51.68%.

Zydus Wellness Ltd has declared a 50% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 50%<BR>- Amount per share: 5<BR>- Ex-date: 19 Jul 24<BR><BR>Dividend Yield: 0.26%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -4.86%, the dividend return was 0%, resulting in a total return of -4.86%.<BR><BR>Over the past year, the price return was 3.51%, the dividend return was 0.26%, leading to a total return of 3.77%.<BR><BR>In the 2-year period, the price return was 28.84%, the dividend return was 0.67%, culminating in a total return of 29.51%.<BR><BR>For the 3-year period, the price return was 23.44%, the dividend return was 0.97%, resulting in a total return of 24.41%.<BR><BR>In the last 4 years, the price return was -7.19%, the dividend return was 0.96%, leading to a total return of -6.23%.<BR><BR>Over the past 5 years, the price return was 50.14%, the dividend return was 1.54%, resulting in a total return of 51.68%.<BR><BR>Overall, Zydus Wellness has declared a dividend, which contributes to a modest dividend yield. The total returns over various periods show a mix of positive and negative performance, with the 5-year period reflecting the strongest total return.

Who are the peers of the Zydus Wellness?

Zydus Wellness peers include Hind. Unilever, ITC, Nestle India, Britannia Inds., and others, with average management risk and below-average growth. Its 1-year return is 14.09%, higher than Honasa Consumer's -32.21% but lower than Manorama Indust.'s 129.10%.

Peers: The peers of Zydus Wellness are Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, CCL Products, Avanti Feeds, Honasa Consumer, Mrs Bectors, and Manorama Indust.<BR><BR>Quality Snapshot: Excellent management risk is observed at ITC, Nestle India, and Britannia Inds., while Good management risk is found at Hind. Unilever, Godrej Consumer, CCL Products, Avanti Feeds, and Mrs Bectors. Average management risk is present at Zydus Wellness and Honasa Consumer. All peers exhibit Below Average growth except for Manorama Indust., which shows Excellent growth, while Zydus Wellness, Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, CCL Products, Avanti Feeds, Honasa Consumer, and Mrs Bectors show Below Average growth. Excellent capital structure is noted for ITC, Nestle India, Britannia Inds., Godrej Consumer, Zydus Wellness, Avanti Feeds, and Mrs Bectors, while CCL Products has Average capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Manorama Indust. at 129.10%, while the lowest is Honasa Consumer at -32.21%. Zydus Wellness has a 1-year return of 14.09%, which is significantly higher than Honasa Consumer but lower than Manorama Indust. Additionally, the six-month returns for Honasa Consumer and Mrs Bectors are negative.

What does Zydus Wellness do?

Zydus Wellness Ltd is a Mid Cap FMCG company specializing in health and wellness products, with reported net sales of ₹9,131 Cr and a net profit of ₹1,719 Cr for the quarter ending March 2025. The company has a market cap of ₹12,843 Cr and key metrics include a P/E ratio of 37.00 and a dividend yield of 0.55%.

Overview:<BR>Zydus Wellness Ltd operates in the FMCG industry and is categorized as a Mid Cap company.<BR><BR>History:<BR>Zydus Wellness Limited was incorporated on November 1, 1994, originally as 'Carnation Health Foods Limited'. The company underwent several name changes, becoming 'Carnation Nutra-Analogue Foods Limited' before finally adopting its current name on January 5, 2009. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 9,131 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 1,719 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: INR 12,843 Cr (Mid Cap)<BR><BR>Key Metrics:<BR>P/E: 37.00 <BR>Industry P/E: 56 <BR>Dividend Yield: 0.55% <BR>Debt-Equity: 0.01 <BR>Return on Equity: 6.02% <BR>Price to Book: 2.26 <BR><BR>Contact Details:<BR>Address: Zydus Corporate Park S No 536, Sarkhej-Gandhinagar Highway Ahmedabad Gujarat : 382481 <BR>Tel: 91-79-67775888 <BR>Email: investor.grievance@zyduswellness.in <BR>Website: http://www.zyduswellness.in

Who are the top shareholders of the Zydus Wellness?

The top shareholders of Zydus Wellness include Zydus Lifesciences Limited with 57.59%, Threpsi Care LLP at 7.27%, and individual investors at 5.91%. Mutual funds hold 11.61%, while foreign institutional investors account for 3.29%, with no pledged promoter holdings reported.

The top shareholders of Zydus Wellness include Zydus Lifesciences Limited, which holds the largest stake at 57.59%. Other significant shareholders are Threpsi Care LLP, with a holding of 7.27%, and individual investors, who collectively own 5.91%. Additionally, mutual funds are represented through 13 schemes, accounting for 11.61% of the shares, while foreign institutional investors (FIIs) hold 3.29% through 101 different entities. There are no pledged promoter holdings reported.

Is Zydus Wellness technically bullish or bearish?

As of November 3, 2025, the trend is mildly bullish with daily moving averages supporting this view, but mixed signals from the MACD and KST suggest a cautious approach.

As of 3 November 2025, the technical trend has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by the daily moving averages indicating bullish momentum. The weekly MACD is mildly bearish, while the monthly MACD remains bullish, suggesting mixed signals across time frames. Bollinger Bands are bullish on both weekly and monthly charts, reinforcing the positive outlook. However, the KST shows a bullish weekly trend but is mildly bearish monthly, indicating some caution. Overall, while there are bullish indicators, the mixed signals suggest a cautious approach.

How has been the historical performance of Zydus Wellness?

Zydus Wellness has shown consistent growth in net sales and profits from March 2020 to March 2025, with net sales increasing from 1,766.82 Cr to 2,708.90 Cr and operating profit peaking at 393.30 Cr, despite some fluctuations in profit margins and cash flow. Total liabilities rose to 6,297.20 Cr, while cash flow from operations improved to 380.00 Cr.

Answer:<BR>The historical performance of Zydus Wellness shows a consistent growth trajectory in net sales and profit over the years, with notable fluctuations in profit margins and cash flow.<BR><BR>Breakdown:<BR>Zydus Wellness has demonstrated significant growth in net sales, increasing from 1,766.82 Cr in March 2020 to 2,708.90 Cr in March 2025. The total operating income has mirrored this growth, reaching 2,708.90 Cr in March 2025, up from 1,766.82 Cr in March 2020. The operating profit (PBDIT) has also shown an upward trend, with a peak of 393.30 Cr in March 2025, although it experienced some fluctuations in previous years. Profit before tax reached 358.80 Cr in March 2025, while profit after tax stood at 346.90 Cr, indicating a healthy profitability despite a slight decline from the previous year. The company’s total liabilities increased to 6,297.20 Cr in March 2025, up from 5,468.89 Cr in March 2020, reflecting a rise in both short-term and long-term borrowings. Cash flow from operating activities improved significantly to 380.00 Cr in March 2025, compared to 259.00 Cr in March 2020, although the net cash outflow was recorded at -13.00 Cr in March 2025. Overall, Zydus Wellness has shown resilience and growth in its financial performance over the years.

Is Zydus Wellness overvalued or undervalued?

As of November 6, 2025, Zydus Wellness is considered overvalued with a valuation grade of expensive, reflected by a PE ratio of 49.20 and a recent 1-week decline of 8.76%, despite a strong year-to-date return of 14.50%.

As of 6 November 2025, the valuation grade for Zydus Wellness has moved from fair to expensive, indicating a shift in its market perception. The company is currently considered overvalued. Key ratios include a PE ratio of 49.20, an EV to EBITDA of 44.54, and a Price to Book Value of 0.25, which suggest that the stock is trading at a premium compared to its earnings and asset value.<BR><BR>In comparison to its peers, Zydus Wellness has a lower PE ratio than Hindustan Unilever, which stands at 54.11, and Nestle India, which has a PE of 81.85. However, the overall valuation of Zydus Wellness remains expensive in the context of the FMCG sector, where many peers are also categorized as very expensive. Despite a strong year-to-date return of 14.50% compared to the Sensex's 6.62%, the stock's recent performance has been lackluster, with a 1-week decline of 8.76%, reinforcing the notion that it may be overvalued at current levels.

When is the next results date for Zydus Wellness Ltd?

The next results date for Zydus Wellness Ltd is February 3, 2026.

The next results date for Zydus Wellness Ltd is scheduled for February 3, 2026.

Are Zydus Wellness Ltd latest results good or bad?

Zydus Wellness Ltd's latest results show strong revenue growth of 108.90% year-on-year, reaching ₹964.90 crores, but the company reported a net loss of ₹39.90 crores, a significant decline from last year's profit, indicating serious profitability challenges despite increased sales. Investors should be cautious due to rising costs and ongoing financial difficulties.

Zydus Wellness Ltd's latest results present a mixed picture, but overall, they indicate significant challenges. While the company achieved impressive revenue growth of 108.90% year-on-year, reaching ₹964.90 crores, it also reported a net loss of ₹39.90 crores for Q3 FY26, a stark contrast to the profit of ₹6.40 crores in the same quarter last year. This represents a dramatic decline in profitability, with the loss increasing by 723.44% year-on-year.<BR><BR>The operating margin improved slightly to 6.33%, but this is still far below historical levels, indicating that despite strong sales, the company is struggling to convert revenue into profit. The substantial rise in interest costs, which surged by over 1,100% to ₹41.20 crores, has heavily impacted the bottom line, alongside a significant increase in depreciation expenses.<BR><BR>In summary, while Zydus Wellness has demonstrated strong revenue growth, the inability to achieve profitability amidst rising costs and operational challenges suggests that the latest results are more concerning than positive. Investors may need to be cautious given the current financial trajectory and the company's ongoing profitability crisis.

Should I buy, sell or hold Zydus Wellness Ltd?

Why is Zydus Wellness Ltd falling/rising?

As of 17-Mar, Zydus Wellness Ltd's stock price is 421.80, down 0.53% after a trend reversal following five days of gains. Despite a strong annual return of 31.59%, the company faces declining profits and negative results in recent quarters, raising concerns about its long-term growth prospects.

As of 17-Mar, Zydus Wellness Ltd's stock price is currently at 421.80, reflecting a decrease of 2.25 (-0.53%). The stock has experienced a trend reversal, falling after five consecutive days of gains. This decline is notable as the stock touched an intraday high of Rs 434.2 earlier in the day but also reached a low of Rs 412.05, indicating volatility.<BR><BR>Despite the recent drop, the stock has shown strong performance over the past year, generating a return of 31.59%, significantly outperforming the market benchmark, which returned only 2.56%. However, this positive performance is contrasted by a decline in profits, which have fallen by 22.6% over the same period. Additionally, the company has reported negative results for the last two consecutive quarters, with a particularly concerning PAT of Rs -33.30 crore, which represents a drastic fall of 146.3% compared to the previous four-quarter average.<BR><BR>Investor participation has increased, with a delivery volume of 22.64 lacs on 16 March, up by 172.58% against the five-day average, suggesting some level of confidence among investors. However, the stock's long-term growth prospects appear poor, with net sales and operating profit growing at annual rates of only 14.15% and 3.21%, respectively, over the last five years. The company's ability to service its debt remains strong, but the overall sentiment may be affected by the recent negative financial results and the stock's current price movement.

Why is Zydus Wellness Ltd falling/rising?

As of 18-Mar, Zydus Wellness Ltd's stock price is rising to Rs 429.20, reflecting a 1.75% increase, driven by strong short-term performance and institutional confidence. However, concerns about declining profits and negative quarterly results may present risks ahead.

As of 18-Mar, Zydus Wellness Ltd is experiencing a rise in its stock price, currently at Rs 429.20, which reflects an increase of Rs 7.4 or 1.75%. This upward movement can be attributed to several factors. Over the past week, the stock has outperformed the benchmark Sensex, gaining 11.60% compared to a slight decline of 0.21% in the index. Additionally, the stock's performance today has outpaced its sector by 1.68%, indicating strong market interest.<BR><BR>The stock reached an intraday high of Rs 434.4, marking a 2.99% increase, which suggests positive trading momentum. Furthermore, Zydus Wellness Ltd has demonstrated a robust return of 31.07% over the past year, significantly outperforming the broader market, which saw a return of only 5.49%. This strong historical performance may attract investors looking for growth opportunities.<BR><BR>However, it is important to note that there are some concerning indicators. The company has faced declining profits, with a reported fall of 22.6% over the past year, and has declared negative results for the last two consecutive quarters. Despite these challenges, the stock's current valuation appears attractive relative to its peers, and high institutional holdings at 21.85% suggest confidence from more knowledgeable investors.<BR><BR>In summary, while Zydus Wellness Ltd is currently rising in stock price due to strong short-term performance and institutional confidence, underlying issues such as declining profits and negative quarterly results could pose risks moving forward.

Why is Zydus Wellness Ltd falling/rising?

As of 19-Mar, Zydus Wellness Ltd's stock price is declining, currently at 414.00, due to underperformance in its sector, decreased investor participation, and significant financial challenges, including rising interest expenses and falling profits. Despite a strong annual return, the company's long-term growth prospects remain weak, contributing to the stock's downward trend.

As of 19-Mar, Zydus Wellness Ltd's stock price is falling, currently at 414.00, which reflects a decrease of 15.2 (-3.54%). This decline can be attributed to several factors. Firstly, the stock has underperformed its sector by 0.76% today, and it touched an intraday low of Rs 410.85, marking a drop of 4.28%. Additionally, the broader FMCG sector has also seen a decline of 2.65%, which may be impacting investor sentiment.<BR><BR>Investor participation has notably decreased, with a delivery volume of 1.39 lacs on March 18, falling by 89.37% compared to the 5-day average. This drop in trading activity suggests a lack of confidence among investors. Furthermore, while the stock has shown strong performance over the past year with a return of 25.19%, it has faced significant challenges recently, including a 36.36% fall in operating profit and negative results declared for the last two consecutive quarters.<BR><BR>The company's financial health is also a concern, as evidenced by a substantial increase in interest expenses, which grew by 749.25% over the latest six months. This, combined with a 55.24% decline in profit after tax (PAT) and a negative profit before tax (PBT) figure, indicates deteriorating financial performance. Despite having a strong ability to service its debt and high institutional holdings, the poor long-term growth prospects, with net sales and operating profit growth rates of only 14.15% and 3.21% respectively over the last five years, contribute to the stock's downward pressure.

Why is Zydus Wellness Ltd falling/rising?

As of 20-Mar, Zydus Wellness Ltd's stock price is rising to 419.90, reflecting a 1.31% increase. This growth is driven by strong trading activity, positive market sentiment, and solid performance metrics, despite some concerns over declining investor participation.

As of 20-Mar, Zydus Wellness Ltd's stock price is rising, currently at 419.90, reflecting a change of 5.45 (1.31%) upwards. This increase can be attributed to several factors. Firstly, the stock has outperformed its sector today by 1.08%, indicating positive market sentiment. Additionally, the stock reached an intraday high of Rs 428.7, which is a 3.44% increase, showcasing strong trading activity.<BR><BR>Over the past week, Zydus Wellness has shown a return of +3.97%, while the benchmark Sensex has remained nearly flat at -0.04%. This trend continues over the past month, where the stock has gained +5.24% compared to a -10.00% decline in the Sensex. Furthermore, the stock has performed well over the past year, generating a return of +25.99%, significantly outperforming the broader market's return of 0.76%.<BR><BR>Despite some concerns regarding falling investor participation, as evidenced by a -90.78% drop in delivery volume compared to the 5-day average, the stock remains liquid enough for trading. The company's strong ability to service its debt, indicated by a healthy EBIT to Interest ratio of 14.07, and attractive valuation metrics contribute to investor confidence.<BR><BR>However, it is important to note that the company has faced challenges, including a decline in operating profit and negative results in recent quarters. Nevertheless, the high institutional holdings at 21.85% suggest that knowledgeable investors continue to support the stock, which may also be influencing its current upward price movement.

Why is Zydus Wellness Ltd falling/rising?

As of 23-Mar, Zydus Wellness Ltd's stock price is declining, currently at 416.40, down 1.97%. This decline is due to a combination of decreased investor interest, poor recent financial performance, and broader market challenges in the FMCG sector.

As of 23-Mar, Zydus Wellness Ltd is experiencing a decline in its stock price, currently at 416.40, down by 8.35 points or 1.97%. This drop can be attributed to several factors. Firstly, the stock opened with a loss of 2.7% today and reached an intraday low of Rs 404.8, reflecting a significant decrease of 4.7%. Additionally, the broader FMCG sector has also fallen by 2.14%, indicating a challenging market environment.<BR><BR>Investor participation has notably decreased, with delivery volume dropping by 91.13% compared to the 5-day average, suggesting reduced interest from investors. Although the stock has performed well over the past year with a return of 25.49%, it has faced negative results in recent quarters, including a 36.36% fall in operating profit and consecutive negative results for the last two quarters. This poor performance is compounded by a significant increase in interest expenses, which grew by 749.25% over the latest six months.<BR><BR>Despite having a strong ability to service its debt and a fair valuation compared to peers, the overall negative trends in sales growth and profitability are contributing to the stock's decline. The combination of these factors indicates that Zydus Wellness Ltd is currently facing challenges that are leading to its falling stock price.

Why is Zydus Wellness Ltd falling/rising?

As of 24-Mar, Zydus Wellness Ltd's stock price is rising to Rs 443.90, up 7.07%, driven by strong market interest and positive trading momentum. Despite recent profit declines, the stock has significantly outperformed the market over the past year, indicating positive investor sentiment.

As of 24-Mar, Zydus Wellness Ltd's stock price is rising, currently at Rs 443.90, reflecting a change of Rs 29.3 or 7.07%. This increase can be attributed to several factors. Firstly, the stock has outperformed the sector by 5.77% today, indicating strong market interest. It reached an intraday high of Rs 443.90, demonstrating positive trading momentum. Additionally, Zydus Wellness is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which typically signals a bullish trend.<BR><BR>Over the past week, the stock has gained 5.24%, while the benchmark Sensex has declined by 2.63%. In the last month, Zydus Wellness has shown an impressive return of 11.27%, contrasting with the Sensex's drop of 9.92%. Furthermore, despite a year-to-date decline of 2.75%, the stock has delivered a remarkable 31.85% return over the past year, significantly outperforming the broader market, which has seen a negative return of 5.02%.<BR><BR>The company's strong ability to service its debt, evidenced by a healthy EBIT to Interest ratio of 14.07, and high institutional holdings at 21.85% suggest confidence among more sophisticated investors. However, it is important to note that while the stock is currently rising, the company has faced challenges, including a decline in profits by 22.6% over the past year and negative results in recent quarters. Despite these issues, the stock's current performance indicates a positive sentiment among investors, contributing to its rising price.

Why is Zydus Wellness Ltd falling/rising?

As of 25-Mar, Zydus Wellness Ltd's stock price is rising to 459.30, up 4.4%, significantly outperforming the Sensex. The stock has shown strong recent performance, with a 7.01% increase over the past week and a total return of 10.78% over the last two days, supported by positive investor sentiment and strong institutional holdings.

As of 25-Mar, Zydus Wellness Ltd's stock price is rising, currently at 459.30, reflecting a change of 19.35 (4.4%) upward. The stock has shown strong performance in recent periods, outperforming the benchmark Sensex significantly. Over the past week, Zydus Wellness has increased by 7.01%, while the Sensex has declined by 1.87%. In the last month, the stock has risen by 16.71%, compared to a drop of 8.51% in the Sensex.<BR><BR>Today's performance indicates that the stock has outperformed its sector by 2.21% and has been on a consecutive gain streak for the last two days, accumulating a total return of 10.78% during this period. The stock reached an intraday high of Rs 469, marking a 6.6% increase. Additionally, Zydus Wellness is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which typically indicates a positive trend.<BR><BR>Investor participation has also increased, with a delivery volume of 1.77 lacs on March 24, representing a 20.53% rise compared to the 5-day average. The FMCG sector, in which Zydus operates, has gained by 2.25%, contributing to the stock's upward movement. Furthermore, the company's strong ability to service its debt, indicated by a healthy EBIT to Interest ratio of 14.07, along with high institutional holdings at 21.85%, suggests confidence among larger investors.<BR><BR>Despite some negative factors, such as a decline in profits over the past year, the stock's overall market performance and positive investor sentiment are driving its current rise.

Which are the latest news on Zydus Wellness?